BC004004 Activators encompass a diverse array of chemical compounds that indirectly stimulate the functional activity of BC004004 through various specific signaling pathways. Compounds such as Forskolin and Genistein exert their effects on BC004004 by modulating the levels of second messengers and kinase activity; Forskolin elevates cAMP, which in turn activates PKA, and this activation could lead to the phosphorylation of substrates and proteins that interact with BC004004. Genistein, through its tyrosine kinase inhibitory action, curtails competitive signaling, potentially freeing up pathways that would facilitate the activation of BC004004. Conversely, lipid-based signaling molecules like Sphingosine-1-phosphate specifically engage with their cognate receptors to initiate signaling cascades that might culminate in the activation of BC004004, particularly if BC004004 is involved in lipid-mediated cellular processes.
Similarly, the modulation of intracellular calciumlevels is a critical regulatory mechanism for BC004004, with chemicals such as Thapsigargin and A23187 (Calcimycin) increasing cytosolic calcium concentrations, thereby potentially triggering calcium-dependent protein activation that could include BC004004. The activation of protein kinase C (PKC) by Phorbol 12-myristate 13-acetate (PMA) also represents a pathway that could indirectly lead to the enhancement of BC004004's activity by phosphorylating proteins within the PKC signaling domain. Additionally, the nuanced control of phosphatidylinositol 3-kinase (PI3K) signaling by LY294002 and Wortmannin, as well as mitogen-activated protein kinase (MAPK) pathways by U0126 and SB203580, provides a potential means to elevate BC004004 activity by alleviating inhibitory signals or shifting the balance of signaling towards pathways that activate BC004004. Epigallocatechin gallate (EGCG) and Staurosporine further contribute to the pool of BC004004 activators by inhibiting kinases that, when active, may suppress BC004004's role in cellular signaling. Collectively, these compounds operate through distinct yet converging pathways that are capable of orchestrating a cellular environment conducive to the activation of BC004004, without necessitating direct binding or interaction with BC004004 itself.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an isoflavone that acts as a tyrosine kinase inhibitor. By inhibiting competitive tyrosine kinase signaling, it can enhance signaling pathways that lead to the activation of BC004004, assuming BC004004 is regulated by tyrosine kinase-dependent pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates sphingosine-1-phosphate receptors, leading to downstream signaling events that can enhance the activity of BC004004 if it is involved in lipid signaling pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a sesquiterpene lactone that inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), causing an increase in cytosolic calcium levels, which can activate calcium-dependent signaling pathways that enhance the activity of BC004004. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diester of phorbol and functions as a potent protein kinase C (PKC) activator. Activation of PKC leads to phosphorylation of target proteins, potentially enhancing the functional activity of BC004004 through PKC-dependent pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3 kinase inhibitor that can lead to the activation of BC004004 by reducing inhibitory signals through the PI3K/Akt pathway, assuming BC004004 functions are upregulated when PI3K signaling is downregulated. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a steroidal metabolite that inhibits PI3K, similar to LY294002, and can indirectly enhance the activation of BC004004 by modulating the PI3K/Akt pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that could enhance the activity of BC004004 by inhibiting the MEK/ERK pathway, assuming that BC004004 activity is regulated via this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may enhance the activity of BC004004 by blocking the p38 MAPK pathway, which may indirectly lead to the activation of BC004004 if it plays a role in stress or inflammatory response signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, activating calcium-dependent proteins and signaling pathways that could enhance the activation of BC004004. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin found in green tea with kinase inhibitor properties. It can enhance the activation of BC004004 by inhibiting kinases that would otherwise suppress BC004004's activity in signaling pathways. | ||||||